DRUG RECALL: Valsartan linked to Cancer

Start A Free Case Evaluation

First Name

Last Name

Phone Number

City

State

By checking this box and providing your number, you are agreeing to receive informational text messages from Alexander Shunnarah Trial Attorneys. Message frequency will vary. Msg & data rates may apply. Reply HELP for help or STOP to opt-out.*

First Name

Last Name

Phone Number

City

State

Have you or a loved one taken the prescription drug Valsartan and been diagnosed with
CANCER?

You may be entitled to financial compensation!

On July 13, 2018, the United States Food and Drug Administration (FDA) alerted healthcare professionals and patients of a voluntary recall of several drug products containing the active ingredient valsartan. The FDA’s recall is due to the unexpected presence of an impurity found in the recalled products called N-nitrosodimethylamine (NDMA), which the FDA has classified as a probable human carcinogen.

If you have been diagnosed with any of the following after taking a recalled Valsartan drug, contact Alexander Shunnarah Trial Attorneys immediately to discuss your case with an attorney: